@intractpharma profile picture
Intract Pharma @intractpharma

An oral drug delivery licensing and product development company offering a range of proprietary formulation technologies for advanced therapeutics.

Joined March 2016
  • Tweets 53
  • Following 71
  • Followers 195
25 Photos and videos
Pinned Tweet
Intract Pharma@intractpharma
9 Nov 2018
We are delighted to announce that we've been awarded an @innovateuk grant to manufacture an oral antibody formulation using #Soteria in partnership with @ukCPI, @Pharmidex and @QuayPharma. Read more here: intractpharma.com/2018/11/09…
5
14
An innovative capsule could take the gold-standard treatment for #CrohnsDisease – infliximab – out of hospital and into patients’ homes for the first time. Find out about how this treatment can benefit Louise Barker from @ukCPI at: hubs.la/Q01bBVRk0 #WorldIBDDay

Infliximab Capsule for At-Home IBD Treatment | CPI

Novel infliximab oral capsule for Crohn's and colitis at-home treatment relieves flare-up symptoms with fewer adverse side effects than injection/ infusion

uk-cpi.com
3
Scientist or Senior Scientist, Oral Protein Formulation job with Intract Pharma jobs.newscientist.com/en-gb/…
3
9
Intract Pharma retweeted
Euronews Next
@euronewsnext
18 Jun 2021
What will the future of healthcare look like? How will technology impact the way you manage your health? Chief Digital Officer at @sanofi shares his predictions 💡👨‍⚕️ euronews.com/next/2021/06/17…

1
10
13
April 22, 2021 | Featured Intract Pharma and NIBEC Enter into an Agreement to Develop a Novel Oral Peptide Therapy for Treatment of Ulcerative Colitis. intractpharma.com/2021/04/22…
1
3
April 01, 2021 | Featured Intract Pharma Enters into Research Collaboration with Ferring Pharmaceuticals to Evaluate Oral delivery of Monoclonal Antibodies for Treatment of Chronic Gastrointestinal Diseases
1
4
August 20, 2020 | Featured Intract Pharma Limited and Celltrion Group announce collaboration for development of oral Infliximab. intractpharma.com/2020/08/20…

Intract Pharma Limited and Celltrion Group announce collaboration for development of oral Inflixi...

Intract Pharma has announced signature to a joint development agreement with Celltrion Inc. and Celltrion Healthcare Co., Ltd. (Celltrion Group) for development of the world’s first oral antibody...

intractpharma.com
1
May 26, 2020 | Featured Intract Pharma and N&S Pharmacy Investment announce partnership to develop orally-delivered GLP-1R agonist peptide therapeutic. intractpharma.com/2020/05/26…
May 05, 2020 | Featured Intract Pharma and Elasmogen Ltd announce collaboration to discover and develop novel, orally-delivered protein therapeutics. intractpharma.com/2020/05/05…
October 24, 2019 | Featured Intract’s Soteria® and Phloral® Technologies Highlighted Among Revolutionary Approaches to Crack Oral Biologics Delivery Challenge intractpharma.com/2019/10/24…
May 07, 2019 | Phloral Carus Animal Health and Intract Pharma Enter Agreement to Develop Novel Drug Delivery Technology.
1
5th April 2019 London, UK and Tokyo, Japan: Intract Pharma Ltd and Neopharma Japan Co. Ltd, have announced entry into a collaboration to develop a novel therapeutic product for treatment of gastrointestinal diseases using Intract’s proprietary drug delivery technologies.
London, England, 27th March 2019. Intract Pharma has announced the launch of a first product incorporating its colon targeting technology, Phloral®. The product - called Yaldigo®/Asacol 1600 has been created and is marketed by Tillotts Pharma AG, Switzerland. @tillotts_pharma
1
Intract Pharma retweeted
Basit Research Group@BasitResearch
12 Sep 2019
Great talk by Vipul Yadav from @intractpharma on their innovative #Phloral and #Soteria oral drug delivery technologies for the delivery of antibodies! @APS_PharmSci #PharmSci2019
2
7
Intract Pharma retweeted
Carus Animal Health@carus_ah
17 Sep 2019
Our partners @intractpharma are working on some exciting drug delivery technologies including enabling biologics, like monoclonal antibodies, to be given as tablets rather than injectables. intractpharma.com/fomulation…
3
5
Intract Pharma retweeted
Carus Animal Health@carus_ah
2 Aug 2019
Medication conundrums - @intractpharma are creating solutions to gut metabolism with innovative new oral drug delivery technology #veterinary #veterinarymedicine #vetinnovation #vetmed intractpharma.com/
1
2
Intract has entered into an agreement with @carus_ah to develop new therapies for the Veterinary Market Read More here: intractpharma.com/2019/05/07… #AnimalHealth #Veterinarian
1
2
We are proud to announce that we've entered into a collaboration with @Neopharma1 to develop a novel treatment for #Gastrointestinal diseases. Read more here: intractpharma.com/2019/04/05…

Intract Pharma Limited and Neopharma Japan Enter into a Collaboration to Develop a Novel Treatment...

5th April 2019, London, UK and Tokyo, Japan: Intract Pharma Ltd (“Intract”) and Neopharma Japan Co. Ltd (“NPJ”), have announced entry into a collaboration to develop a novel therapeutic product for...

intractpharma.com
3
Market launch of a first Phloral® coated product, read more here: intractpharma.com/2019/03/27…
2
Intract Pharma retweeted
UCL School of Pharmacy@School_Pharmacy
12 Mar 2019
Our colleagues @intractpharma , a spin out company from the @School_Pharmacy, have successfully been awarded over £1.4million in funding from @innovateuk to develop a scalable manufacturing process for novel oral antibody products. Read more: bit.ly/2THQ0iL
4
8
Head on over to intractpharma.com to see our new Phloral® and Soteria® videos!
2
Load more